mBio Diagnostics
Click to visit the mBio Diagnostics website »
MBio Diagnostics, Inc. was originally established as a division of PPC. MBio’s management brings technology commercialization skills from over a decade of commercial success at PPC. To complement the instrumentation expertise of the company’s founders, MBio has assembled a team of diagnostic industry veterans and has established strong relationships with a world-class group of clinical collaborators. Similar to PPC, MBio also has an active Silicon Valley based investor group (Incubic, LLC) that has provided seed financing and ongoing business guidance. MBio Diagnostics, Inc. spun out of Precision Photonics in late 2009 and is now a privately held company based in Boulder.
MBio has successfully built prototypes of a low-cost diagnostic instrument, developed key infectious disease assays on inexpensive disposable cartridges, and delivered them to collaborators in locations around the world. MBio has validated the technology with over 20,000 test cartridges, and nearly 1,000 patient samples. MBio is moving quickly towards regulatory approvals for initial applications, and is now opening the platform for researchers, developers, and partners.